Brazilian research network on tuberculosis: scientific development Mission to eliminate tuberculosis

Authors

  • Rander Junior Rosa Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Ana Beatriz Marques Valença Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Letícia Perticarrara Ferezin Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Natacha Martins Ribeiro Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Paula Daniella de Abreu Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Rubia Laine de Paula Andrade Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Willie Otávio Bueno Bernardi Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Diogo Henrique Mendes da Silva Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Aline Aparecida Monroe Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Erica Chimara Silva Instituto Adolfo Lutz, São Paulo, São Paulo, Brasil.
  • Vânia Maria Silva Araújo Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
  • Anna Cristina Calçada Carvalho Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brasil.
  • Ethel Leonor Noia Maciel Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brasil.
  • Ana Paula Junqueira-Kipnis Universidade Federal de Goiás, Goiânia, Goiás Brasil.
  • Jose Roberto Lapa e Silva Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brasil.
  • Lia Gonçalves Possuelo Universidade de Santa Cruz do Sul, Santa Cruz, Rio Grande do Sul, Brasil.
  • Ricardo Alexandre Arcêncio Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.

DOI:

https://doi.org/10.17058/reci.v14i3.19425

Keywords:

Tuberculosis, BCG, Technology

Abstract

Background and Objectives: Since its inception, the Brazilian Tuberculosis Research Network (REDE-TB) has contributed significantly to scientific and technological advances in Brazil. This study analyzes this contribution in the strategic areas of tuberculosis prevention, diagnosis, and treatment, which are relevant for achieving the 2030 Agenda to End Tuberculosis. Methods: This research is based on a survey of the Lilacs and Embase/MEDLINE databases, focusing on primary and secondary studies on tuberculosis published by members of REDE-TB between 2018 and 2023. Data on identification, scope, study location, design, area, and population studied were extracted. Descriptive statistics and georeferencing were used for the analysis. Results: A total of 670 publications were identified, of which 447 were included in the review. Of these, 315 (70.5%) were published in international journals. Most studies in Brazil were conducted in Rio de Janeiro (29.0%), followed by São Paulo (19.2%), Rio Grande do Sul (13.8%), Paraná (11.6%) and Amazonas (10.7%). After Brazil, 24 (8.0%) studies were conducted in India, followed by South Africa (16 - 5.3%) and Uganda (10 - 3.3%). The studies had different designs, including literature reviews and epidemiologic studies, and focused primarily on tuberculosis disease (56.4%) and, to a lesser extent, tuberculosis infection (12.6%). Conclusions: The study highlights the importance of the Brazilian Research Network on Tuberculosis (REDE-TB) in the scientific production related to tuberculosis, contributing to policies and actions aimed at combating the disease in Brazil and around the world.

Downloads

Download data is not yet available.

References

DA SILVA VIEIRA MC, et al. A associação entre o SNP RS2243250 de IL-4 e a susceptibilidade à tuberculose: uma meta-análise de estudos caso-controle. The Brazilian Journal of Infectious Diseases. 2023; 27: 103597. Disponível em: https://www.sciencedirect.com/science/article/pii/S1413867023008577. Acesso em: 10 set. 2024.

BRASIL. Boletim Epidemiológico de Tuberculose. Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV/Aids, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis; 2024. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2024/boletim-epidemiologico-de-tuberculose-numero-especial-mar-2024.pdf/view. Acesso em: 10 set. 2024.

OMS – Organização Mundial da Saúde. The end TB strategy. 2015. Disponível em:

https://iris.who.int/bitstream/handle/10665/331326/WHO-HTM-TB-2015.19-eng.pdf?sequence=1 . Acesso em: 8 jan. 2024.

JEONG Y, MIN J. Impact of COVID-19 pandemic on tuberculosis preventive services and their post-pandemic recovery strategies: a rapid review of literature. Journal of Korean Medical Science. 2023;38(5). https://doi.org/10.3346/jkms.2023.38.e43

WHO. World Health Organization. Global Tuberculosis Report 2017. Geneva: WHO; 2017. Available in: https://www.who.int/teams/global-tuberculosis-programme/tb-reports 08 fev. 2024.

Maciel EL, Arcêncio RA, Silva JRL. Rede Brasileira de Pesquisa em Tuberculose: 20 anos de história na luta contra a Tuberculose. Jornal Brasileiro de Pneumologia. 2021;47. https://doi.org/10.36416/1806-3756/e20210341

Kritski A, Dalcolmo MP, Mello FCQ, Carvalho ACC, Silva DR, Oliveira MMD, et al. O papel da Rede Brasileira de Pesquisas em Tuberculose nos esforços nacionais e internacionais para a eliminação da tuberculose. Jornal Brasileiro de Pneumologia, 44, 77-81.6. MACNEIL, A. et al. Global epidemiology of tuberculosis and progress toward achieving global targets—2017. Morbidity and Mortality Weekly Report. 2019 Apr; 68(11): 263. https://doi.org/10.1590/S1806-37562017000000435

Rede Brasileira de Pesquisa em Tuberculose (Rede TB). Diretoria. Disponível em: https://redetb.org.br/category/diretoria/. Acesso em: 22 out. 2024.

Lienhardt C, et al. What research is needed to stop TB? Introducing the TB Research Movement. PLoS Medicine. 2011;8(11). https://doi.org/10.1371/journal.pmed.1001135.

Ferreira N, Sandra A. As pesquisas denominadas" estado da arte". Educação & sociedade. 2002; 23: 257-272.

Sahu S, Ditiu L, Zumla A. After the UNGA High-Level Meeting on Tuberculosis—what next and how?. 2019; The Lancet Global Health, 7(5) e558-e560.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Systematic reviews. 2016 Dec; 5: 1-10. https://doi.org/10.1186/s13643-016-0384-4.

Sharif N, et al. Comparação de diferentes modalidades de diagnóstico para isolamento de Mycobacterium tuberculosis entre pacientes com suspeita de linfadenite tuberculosa. Brazilian Journal of Biology. 2021; 83: 244311. https://doi.org/10.1590/1519-6984.244311

- WHO, National surveys of costs faced by tuberculosis patients and their households 2015–2021. Geneva: World Health Organization, 2022. ISBN 978-92-4-006553-6 (electronic version), ISBN 978-92-4-006554-3 (print version).

Maciel ELN, et al. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021. PLoS One. 2023;18.

Curioso WH, Brunette, Maria J. Inteligencia artificial e innovación para optimizar el proceso de diagnóstico de la tuberculosis. Revista peruana de medicina experimental y salud pública. 2020; 37, 554-558. https://doi.org/10.17843/rpmesp.2020.373.5585

Padura R, Fonseca FCB. BRICS: potencialidades de cooperação e papel na governança global de saúde no contexto da pandemia. Saúde em Debate. 2020; 44(spe4): 40-61. https://doi.org/10.1590/0103-11042020E402

Torres-Pascual C, Sánchez-Pérez HJ, Àvila-Castells P. Distribución geográfica y colaboración internacional de las publicaciones científicas latinoamericanas y del Caribe sobre tuberculosis en PubMed. Revista Peruana de Medicina Experimental y Salud Pública, 2021(38) 49-57. https://doi.org/10.17843/rpmesp.2021.381.5726

WORLD HEALTH ORGANIZATION. Global tuberculosis report 2021: supplementary material. World Health Organization, 2022. Disponível em: https://books.google.com.br/books?hl=ptBR&lr=&id=DHkOEQAAQBAJ&oi=fnd&pg=PA1. Acesso em: 20 out. 2024.

Comella-del-Barrio P, De Souza GML, Prat-Aymerich C, Domínguez J. (2021). Impact of COVID-19 on tuberculosis control. Archivos de bronconeumologia. 2021; 57(5). https://doi.org/10.1016/j.arbres.2020.11.016

Alene KA, Wangdi K, Clements AC. Impact of the COVID-19 pandemic on tuberculosis control: an overview. Tropical medicine and infectious disease. 2020; 5(3), 123. https://www.mdpi.com/2414-6366/5/3/123

Riccaboni M, Verginer L. (2022). The impact of the COVID-19 pandemic on scientific research in the life sciences. PLoS One. 2022 Feb; 17(2): e0263001. https://doi.org/10.1371/journal.pone.0263001

Raju R, et al. Experience of “One Stop TB Diagnostic Solution” Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India. Diagnostics. 2023; 13(17), 2823. https://doi.org/10.3390/diagnostics13172823

Cardoso GCP, et al. Sítios simbólicos de pertencimento e prevenção e controle da tuberculose: percepções e práticas dos Agentes Comunitários de Saúde no Brasil e na Etiópia. Ciência & Saúde Coletiva. 2020; 25(8): 2927-2937. https://doi.org/10.1590/1413-81232020258.23682018

Migliori GB, et al. Tuberculosis, COVID-19 and hospital admission: consensus on pros and cons based on a review of the evidence. Pulmonology 2021; 27(3) 248-256. https://doi.org/10.1016/j.pulmoe.2020.12.016

Gioseffi JR, Brignol SMS, Werneck GL. Perfil sociodemográfico das pessoas em situação de rua notificadas com tuberculose no Município do Rio de Janeiro, Brasil, nos anos de 2015 a 2019. Cadernos de Saúde Pública. 2023; 39, e00051122. https://doi.org/10.1016/j.pulmoe.2020.12.016

Pereira ALG, et al. Análise do perfil epidemiológico da tuberculose no estado de Minas Gerais/Analysis of the epidemiological profile of tuberculosis in Minas Gerais state. Brazilian Journal of Health Review.[Internet]. 2022, 4332-42. https://doi.org/10.34119/bjhrv5n2-028

Do Carmo Guimarães JL, et al. Whole-genome sequencing as a tool for studying the microevolution of drug-resistant serial Mycobacterium tuberculosis isolates. Tuberculosis. 2021;131:102137. https://doi.org/10.1016/j.tube.2021.102137.

Santos AR, et al. Perfil clínico e epidemiológico da tuberculose no município de Juara, estado de mato Grosso. Revista Inspirar movimento & saúde. 2020; 20(1). Disponível em: https://www.editorarealize.com.br/editora/anais/conbracis/2020/TRABALHO_EV135_MD1_SA17_ID775_29102020151457.pdf

Nascimento DD, et al. Medicamento para Tuberculose em dose fixa combinada: um panorama dos fármacos rifampicina, isoniazida, pirazinamida e etambutol. Brazilian Journal of Health Review. 2023; 6(4): 15780-15802. https://doi.org/10.34119/bjhrv6n4-143

OMS, Relatório Mundial sobre TB. Organização Mundial de Saúde; Genebra: 2021. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/tratamento_diretamente_observado_tuberculose.pdf. Acesso em: 24 jan. 2024.

Relatório global sobre tuberculose 2020. Genebra: OMS; 2020. Organização Mundial da Saúde – OMS. Relatório nº: 9789240013131. Disponível em: https://iris.who.int/bitstream/handle/10665/336069/9789240013131-eng.pdf?sequence=1. Acesso em: 10 dez. 2023

Grangeiro A, Castanheira ER, Nemes MIB. The reemergence of the Aids epidemic in Brazil: Challenges and perspectives to tackle the disease. Interface-Comunicação, Saúde, Educação. 2015 Mar; 19, 5-8. https://doi.org/10.1590/1807-57622015.0038

Fernández LG, et al. New opportunities in tuberculosis prevention: implications for people living with HIV. African Journal of Reproduction and Gynaecological Endoscopy. 2020;23(1). http://dx.doi.org/10.1002/jia2.25438.

Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho CCA, et al. Tuberculosis elimination: where are we now?. European Respiratory Review. 2018; 27(148). https://doi.org/10.1183/16000617.0035-2018

Kuddus Md A, et al. Scenario analysis for programmatic tuberculosis control in Bangladesh: a mathematical modelling study. Scientific Reports. 2021;11(1):4354. https://doi.org/10.1038/s41598-021-83768-y

Clark RA, et al. Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study. The Lancet Regional Health-Southeast Asia. 2024. https://doi.org/10.5281/zenodo.6421372

Ministério da Saúde. Boletim Epidemiológico de Tuberculose: Número Especial - Março de 2022. Brasília: Ministério da Saúde, 2022. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2022/boletim-epidemiologico-de-tuberculose-numero-especial-marco-2022.pdf. Acesso em: 22 out. 2024.

Published

2024-12-04

How to Cite

Rosa, R. J., Marques Valença , A. B., Perticarrara Ferezin, L. ., Martins Ribeiro, N. . ., de Abreu, P. D. ., Laine de Paula Andrade, R. ., Bueno Bernardi , W. O. . ., Mendes da Silva, D. H. ., Aparecida Monroe, A. . ., Chimara Silva, E. . ., Silva Araújo, V. M. ., Calçada Carvalho, A. C. . ., Leonor Noia Maciel, E., Junqueira-Kipnis , A. P. ., Lapa e Silva , J. R. ., Gonçalves Possuelo , L. ., & Arcêncio, R. A. (2024). Brazilian research network on tuberculosis: scientific development Mission to eliminate tuberculosis. Revista De Epidemiologia E Controle De Infecção, 14(3). https://doi.org/10.17058/reci.v14i3.19425

Issue

Section

ORIGINAL ARTICLE